{
  "url": "https://www.iccr-cancer.org/datasets/published-datasets/endocrine/thyroid/",
  "title": "Carcinomas of the Thyroid",
  "introduction": "",
  "scope": "",
  "authors": [],
  "sections": [
    {
      "title": "Scope",
      "content": "Datasets\n>\nPublished Datasets\n>\nEndocrine Organs\n>\nCarcinomas of the Thyroid\nScope\nThe dataset has been developed for the pathology reporting of thyroid resection specimens for carcinoma. Core needle biopsies and metastasis to the thyroid gland are not included. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), tumours of uncertain malignant potential (UMP), thyroid carcinomas arising from struma ovarii, thyroid carcinomas arising in thyroglossal duct cysts, sarcomas and lymphomas are not covered in the dataset.\nFurther details of the scope of this dataset are outlined within the reporting guide."
    },
    {
      "title": "Publication History",
      "content": "Publication History\n3rd edition\n– November 2025\nUpdated following the publication of the 2025 World Health Organization (WHO) Classification of Endocrine and Neuroendocrine Tumours, 5th edition.\nSUMMARY OF CHANGES\n• Updated to Union for International Cancer Control TNM9 staging, including errata published October 2025.\n• Revised guide to harmonise with ICCR style for element titles and value list.\n• Revised scope for clarity and to harmonise with ICCR style.\n• Updated the ‘Clinical information’ element.\n• Updated the ‘Operative findings’ element.\n• Added a new non-core element ‘Block identification key’.\n• Updated the ‘Histological tumour type’ element to the 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours.\n• Renamed the ‘Mitotic activity’ element to ‘Mitotic count’ and updated.\n• Removed the element ‘Histological tumour grade’.\n• Renamed the ‘Necrosis’ element ‘Tumour necrosis’.\n• Renamed the ‘Lymphatic or blood vessel invasion’ element to make two new elements ‘Lymphatic invasion’ and ‘Vascular invasion’.\n• Updated the ‘Margin status’ element.\n• Removed the element ‘C-cell hyperplasia’.\n• Updated the ‘Coexistent pathology’ element.\n• ‘Ancillary studies’ was changed to a core element and expanded. ‘Representative blocks for ancillary studies’ was added as non-core.\n• Other minor updates to elements were also included.\n• Revised all notes, including incorporation of the 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours.\nTo reference this dataset please use the following citation:\nGhossein R, Abrosimov AY, Al Ghuzlan A, Barletta J, Fuchs TL, Kondo T, Mete O, Moonim MT, Poller DN, Tallini G, Tuttle RM, Viswanathan K, Xu B, Lax SF, Gill AJ (2025).\nCarcinoma of the thyroid Histopathology Reporting Guide. 3rd edition\n. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-922324-71-9.\n2nd edition\n– June 2020\nUpdated following revision of Lymphovascular invasion.\nTo reference this dataset please use the following citation:\nGhossein R, Barletta J, Bullock M, Johnson S, Kakudo K, Lam A, Moonim MT, Poller D, Tallini G, Tuttle RM, Xu B, Gill A (2020).\nCarcinoma of the Thyroid Histopathology Reporting Guide\n.\n2nd edition\n. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-922324-08-5.\nRead more on the Carcinoma of the thyroid dataset from the journal article written by the dataset authors:\nData set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting\n. Ghossein R, Barletta JA, Bullock M, Johnson SJ, Kakudo K, Lam AK, Moonim MT, Poller DN, Tallini G, Tuttle RM, Xu B, Gill AJ. Hum Pathol. 2021 Apr;110:62-72. doi: 10.1016/j.humpath.2020.08.009. Epub 2020 Sep 10.\n1st edition\n– December 2019\nTo reference this dataset please use the following citation:\nGhossein R, Barletta J, Bullock M, Johnson S, Kakudo K, Lam A, Moonim MT, Poller D, Tallini G, Tuttle RM, Xu B, Gill A (2019).\nCarcinoma of the Thyroid Histopathology Reporting Guide\n.\n1st\nedition\n. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-925687-27-9.\nExpert Committee\nThe 3rd edition of the dataset for Carcinoma of the thyroid was developed by the following international team:\nChair – Ronald Ghossein, USA\nSeries Champion – Anthony Gill, Australia\nICCR representative – Sigurd Lax, Austria\nDomain experts:\nAlexander Abrosimov, Russia\nAbir Al Ghuzlan, France\nJustine Barletta, USA\nTalia Fuchs, Australia\nTetsuo Kondo, Japan\nOzgur Mete, Canada\nMufaddal Moonim, UK\nDavid Poller, UK\nGiovanni Tallini, Italy\nRobert Michael Tuttle, USA\nKartik Viswanathan, USA\nBin Xu, USA\nAuthors of the previous editions of this dataset are available\nhere\n."
    }
  ],
  "data_items": [],
  "references": [],
  "version_info": "",
  "full_text": "Datasets\n>\nPublished Datasets\n>\nEndocrine Organs\n>\nCarcinomas of the Thyroid\nScope\nThe dataset has been developed for the pathology reporting of thyroid resection specimens for carcinoma. Core needle biopsies and metastasis to the thyroid gland are not included. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), tumours of uncertain malignant potential (UMP), thyroid carcinomas arising from struma ovarii, thyroid carcinomas arising in thyroglossal duct cysts, sarcomas and lymphomas are not covered in the dataset.\nFurther details of the scope of this dataset are outlined within the reporting guide.\n\nPublication History\n3rd edition\n– November 2025\nUpdated following the publication of the 2025 World Health Organization (WHO) Classification of Endocrine and Neuroendocrine Tumours, 5th edition.\nSUMMARY OF CHANGES\n• Updated to Union for International Cancer Control TNM9 staging, including errata published October 2025.\n• Revised guide to harmonise with ICCR style for element titles and value list.\n• Revised scope for clarity and to harmonise with ICCR style.\n• Updated the ‘Clinical information’ element.\n• Updated the ‘Operative findings’ element.\n• Added a new non-core element ‘Block identification key’.\n• Updated the ‘Histological tumour type’ element to the 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours.\n• Renamed the ‘Mitotic activity’ element to ‘Mitotic count’ and updated.\n• Removed the element ‘Histological tumour grade’.\n• Renamed the ‘Necrosis’ element ‘Tumour necrosis’.\n• Renamed the ‘Lymphatic or blood vessel invasion’ element to make two new elements ‘Lymphatic invasion’ and ‘Vascular invasion’.\n• Updated the ‘Margin status’ element.\n• Removed the element ‘C-cell hyperplasia’.\n• Updated the ‘Coexistent pathology’ element.\n• ‘Ancillary studies’ was changed to a core element and expanded. ‘Representative blocks for ancillary studies’ was added as non-core.\n• Other minor updates to elements were also included.\n• Revised all notes, including incorporation of the 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours.\nTo reference this dataset please use the following citation:\nGhossein R, Abrosimov AY, Al Ghuzlan A, Barletta J, Fuchs TL, Kondo T, Mete O, Moonim MT, Poller DN, Tallini G, Tuttle RM, Viswanathan K, Xu B, Lax SF, Gill AJ (2025).\nCarcinoma of the thyroid Histopathology Reporting Guide. 3rd edition\n. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-922324-71-9.\n2nd edition\n– June 2020\nUpdated following revision of Lymphovascular invasion.\nTo reference this dataset please use the following citation:\nGhossein R, Barletta J, Bullock M, Johnson S, Kakudo K, Lam A, Moonim MT, Poller D, Tallini G, Tuttle RM, Xu B, Gill A (2020).\nCarcinoma of the Thyroid Histopathology Reporting Guide\n.\n2nd edition\n. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-922324-08-5.\nRead more on the Carcinoma of the thyroid dataset from the journal article written by the dataset authors:\nData set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting\n. Ghossein R, Barletta JA, Bullock M, Johnson SJ, Kakudo K, Lam AK, Moonim MT, Poller DN, Tallini G, Tuttle RM, Xu B, Gill AJ. Hum Pathol. 2021 Apr;110:62-72. doi: 10.1016/j.humpath.2020.08.009. Epub 2020 Sep 10.\n1st edition\n– December 2019\nTo reference this dataset please use the following citation:\nGhossein R, Barletta J, Bullock M, Johnson S, Kakudo K, Lam A, Moonim MT, Poller D, Tallini G, Tuttle RM, Xu B, Gill A (2019).\nCarcinoma of the Thyroid Histopathology Reporting Guide\n.\n1st\nedition\n. International Collaboration on Cancer Reporting; Sydney, Australia. ISBN: 978-1-925687-27-9.\nExpert Committee\nThe 3rd edition of the dataset for Carcinoma of the thyroid was developed by the following international team:\nChair – Ronald Ghossein, USA\nSeries Champion – Anthony Gill, Australia\nICCR representative – Sigurd Lax, Austria\nDomain experts:\nAlexander Abrosimov, Russia\nAbir Al Ghuzlan, France\nJustine Barletta, USA\nTalia Fuchs, Australia\nTetsuo Kondo, Japan\nOzgur Mete, Canada\nMufaddal Moonim, UK\nDavid Poller, UK\nGiovanni Tallini, Italy\nRobert Michael Tuttle, USA\nKartik Viswanathan, USA\nBin Xu, USA\nAuthors of the previous editions of this dataset are available\nhere\n.",
  "category": "endocrine",
  "slug": "thyroid"
}